自然免疫応答を制御する新規免疫受容体CD300HとAllergin-1の機能解明

この博士論文は内容の要約のみの公開（または一部非公開）になっています筑波大学 (University of Tsukuba)201

自然免疫応答を制御する新規免疫受容体CD300HとAllergin-1の機能解明

筑波大学 (University of Tsukuba)201

sj-pdf-2-jcb-10.1177_0271678X231202594 - Supplemental material for Randomized placebo-controlled trial of CL2020, an allogenic muse cell–based product, in subacute ischemic stroke

Supplemental material, sj-pdf-2-jcb-10.1177_0271678X231202594 for Randomized placebo-controlled trial of CL2020, an allogenic muse cell–based product, in subacute ischemic stroke by Kuniyasu Niizuma, Shin-Ichiro Osawa, Hidenori Endo, Shin-Ichi Izumi, Kota Ataka, Akihiro Hirakawa, Masao Iwano and Teiji Tominaga in Journal of Cerebral Blood Flow & Metabolism</p

sj-pdf-1-jcb-10.1177_0271678X231202594 - Supplemental material for Randomized placebo-controlled trial of CL2020, an allogenic muse cell–based product, in subacute ischemic stroke

Supplemental material, sj-pdf-1-jcb-10.1177_0271678X231202594 for Randomized placebo-controlled trial of CL2020, an allogenic muse cell–based product, in subacute ischemic stroke by Kuniyasu Niizuma, Shin-Ichiro Osawa, Hidenori Endo, Shin-Ichi Izumi, Kota Ataka, Akihiro Hirakawa, Masao Iwano and Teiji Tominaga in Journal of Cerebral Blood Flow & Metabolism</p

sj-pdf-3-jcb-10.1177_0271678X231202594 - Supplemental material for Randomized placebo-controlled trial of CL2020, an allogenic muse cell–based product, in subacute ischemic stroke

Supplemental material, sj-pdf-3-jcb-10.1177_0271678X231202594 for Randomized placebo-controlled trial of CL2020, an allogenic muse cell–based product, in subacute ischemic stroke by Kuniyasu Niizuma, Shin-Ichiro Osawa, Hidenori Endo, Shin-Ichi Izumi, Kota Ataka, Akihiro Hirakawa, Masao Iwano and Teiji Tominaga in Journal of Cerebral Blood Flow & Metabolism</p